These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 32532246

  • 1. Activation of FoxO1/SIRT1/RANKL/OPG pathway may underlie the therapeutic effects of resveratrol on aging-dependent male osteoporosis.
    Ameen O, Yassien RI, Naguib YM.
    BMC Musculoskelet Disord; 2020 Jun 12; 21(1):375. PubMed ID: 32532246
    [Abstract] [Full Text] [Related]

  • 2. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
    He XF, Zhang L, Zhang CH, Zhao CR, Li H, Zhang LF, Tian GF, Guo MF, Dai Z, Sui FG.
    Bosn J Basic Med Sci; 2017 Nov 20; 17(4):295-301. PubMed ID: 29055350
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol promotes osteogenesis via activating SIRT1/FoxO1 pathway in osteoporosis mice.
    Jiang Y, Luo W, Wang B, Wang X, Gong P, Xiong Y.
    Life Sci; 2020 Apr 01; 246():117422. PubMed ID: 32057903
    [Abstract] [Full Text] [Related]

  • 4. Resveratrol restores the level of key inflammatory cytokines and RANKL/OPG ratio in the femur of rat osteoporosis model.
    Khera A, Kanta P, Kalra J, Dumir D, M T.
    J Women Aging; 2019 Apr 01; 31(6):540-552. PubMed ID: 30239309
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
    Liu F, Tan F, Tong W, Fan Q, Ye S, Lu S, Teng Z, Han M, Zhang M, Chai Y.
    Biomed Pharmacother; 2018 Jul 01; 103():1052-1060. PubMed ID: 29710663
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Heamatococcus pluvialis ameliorates bone loss in experimentally-induced osteoporosis in rats via the regulation of OPG/RANKL pathway.
    El-Baz FK, Saleh DO, Abdel Jaleel GA, Hussein RA, Hassan A.
    Biomed Pharmacother; 2019 Aug 01; 116():109017. PubMed ID: 31158803
    [Abstract] [Full Text] [Related]

  • 14. Resveratrol prevents osteoporosis by upregulating FoxO1 transcriptional activity.
    Feng YL, Jiang XT, Ma FF, Han J, Tang XL.
    Int J Mol Med; 2018 Jan 01; 41(1):202-212. PubMed ID: 29115382
    [Abstract] [Full Text] [Related]

  • 15. Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause.
    Wang X, Lu C, Chen Y, Wang Q, Bao X, Zhang Z, Huang X.
    Climacteric; 2023 Feb 01; 26(1):25-33. PubMed ID: 35674253
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.
    Zupan J, Komadina R, Marc J.
    J Biomed Sci; 2012 Mar 01; 19(1):28. PubMed ID: 22380539
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells.
    Shakibaei M, Buhrmann C, Mobasheri A.
    J Biol Chem; 2011 Apr 01; 286(13):11492-505. PubMed ID: 21239502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.